The global orthopedic biomaterials market is entering a sustained growth phase as the rising prevalence of musculoskeletal disorders, an expanding elderly population, and increasing orthopedic surgical volumes strengthen demand for high-performance implant materials. Valued at USD 25.8 billion in 2025, the market is projected to reach USD 56.6 billion by 2036, expanding at a CAGR of 7.4% from...